4.4 Article

Risk factors for drug-resistant epilepsy in adult patients

Journal

MEDICINA CLINICA
Volume 160, Issue 12, Pages 547-550

Publisher

ELSEVIER ESPANA SLU
DOI: 10.1016/j.medcli.2023.03.006

Keywords

Drug-resistant epilepsy; Anti-seizure medications; Refractory epilepsy; Drug-sensitive epilepsy; Pharmacoresistance

Ask authors/readers for more resources

This study aimed to identify risk factors for drug-resistant epilepsy by comparing the characteristics of patients with drug-sensitive epilepsy and drug-resistant epilepsy. The results showed that risk factors for drug-resistant epilepsy included febrile seizures, focal epilepsy, focal seizures with loss of consciousness, structural etiology, and abnormal MRI.
Introduction: Drug-resistant epilepsy occurs in about 30% of epilepsy patients. It has been suggested that etiology or seizure type would increase the risk of pharmacoresistance. This study aims to compare the characteristics of patients with drug-sensitive epilepsy with patients with drug-resistant epilepsy to identify risk factors.Patient and methods: A multicentric cohort study was conducted between 2019 and 2022. We included patients >18 years-old with epilepsy but excluded psychogenic non-epileptic seizures and less than 2 years of follow-up.Results: We included 128 patients, of whom 46 had drug-resistance epilepsy, and 82 responding to medication. Both groups showed similar characteristics. Febrile seizures (OR: 7.25), focal epilepsy (OR: 2.4), focal seizures with loss of consciousness (OR: 2.36), structural etiology (OR: 2.2) and abnormal MRI (OR: 4.6) were significant risk factors for drug-resistance epilepsy.Conclusion: Following other studies, we observed that factors such as epilepsy type, seizure type, structural etiology, abnormal MRI, and febrile seizure increased the risk for drug-resistance epilepsy, in our population.& COPY; 2023 Elsevier Espan & SIM;a, S.L.U. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available